Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. M. Carella
Treatment of Refractory and Relapsed Hodgkin's Lymphoma: Facts and Perspectives
Haematologica
Hematology
Related publications
PD-1 Blockade With Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
New England Journal of Medicine
Medicine
Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group
Klinicka Onkologie
Oncology
Prognostic Value of Comorbidity for Auto-SCT Eligibility and Outcome in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Copanlisib Treatment of Patients With Relapsed or Refractory Marginal Zone Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Profile of Brentuximab Vedotin and Its Potential in the Treatment of Relapsed or Refractory Hodgkin Lymphoma
Blood and Lymphatic Cancer: Targets and Therapy
LACE-conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: Treatment Outcome and Risk Factor Analysis in 67 Patients From a Single Centre
Bone Marrow Transplantation
Transplantation
Hematology
Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma
Current Oncology
Oncology
Targeted Drug Brentuximab Vedotin for Treatment of Relapsed or Refractory Cd30-Positive Hodgkin’s Lymphoma
Malignant tumours
Treating Hodgkin Lymphoma in the New Millennium: Relapsed and Refractory Disease
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
